Recycling old antivax tropes as “bioethics”-based arguments against COVID-19 vaccination for children
A recently published article in Bioethics makes ethical arguments against vaccinating children against COVID-19. If you change the word "COVID-19" to measles, chickenpox, or rotavirus (or others), this article could have been published on one of the higher-brow antivax websites in 2010. Antivax arguments never change; they're just continually recycled.
Last week, The BMJ published an "exposé" by Paul Thacker alleging patient unblinding, data falsification, and other wrongdoing by a company running three sites for the massive clinical trial of the Pfizer COVID-19 vaccine. It was a highly biased story embraced by antivaxxers, with a deceptively framed narrative and claims not placed into proper context, leading me to look into the broader...
“Imbalanced Energy Field” is not a valid diagnosis and therapeutic touch is pseudoscience, so why can’t nurses just give it up?
“Imbalanced Energy Field” is not a valid diagnosis and therapeutic touch is pseudoscience. It's past time nursing gave up both.
A critical, science-based analysis of Abigail Shrier's book Irreversible Damage.
A veteran's adult idiopathic scoliosis was treated at a VA health clinic with acupuncture and cupping in an attempt to correct his spinal curvature, an impossibility without surgery. The ideology of so-called integrative medicine is firmly entrenched at the VA, to the detriment of veterans and taxpayers.
Alice Dreger's book recounts many instances of shooting the messenger, when scientists were persecuted for research findings that activists found objectionable. Social justice matters, but it should rely on science and reality, not ideology.
Libella Gene Therapeutics, LLC made the news last week for announcing a "pay-to-play" trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a "pay-to-play" trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn't...